These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
98 related articles for article (PubMed ID: 24768264)
21. Validation and clinical application of a high performance liquid chromatography tandem mass spectrometry (LC-MS/MS) method for the quantitative determination of 10 anti-retrovirals in human peripheral blood mononuclear cells. Elens L; Veriter S; Yombi JC; Di Fazio V; Vanbinst R; Lison D; Wallemacq P; Vandercam B; Haufroid V J Chromatogr B Analyt Technol Biomed Life Sci; 2009 Jul; 877(20-21):1805-14. PubMed ID: 19487167 [TBL] [Abstract][Full Text] [Related]
22. The current role of liquid chromatography-tandem mass spectrometry in therapeutic drug monitoring of immunosuppressant and antiretroviral drugs. Taylor PJ; Tai CH; Franklin ME; Pillans PI Clin Biochem; 2011 Jan; 44(1):14-20. PubMed ID: 20599871 [TBL] [Abstract][Full Text] [Related]
23. Pharmacokinetic/pharmacodynamic relationships of antimicrobial drugs used in veterinary medicine. McKellar QA; Sanchez Bruni SF; Jones DG J Vet Pharmacol Ther; 2004 Dec; 27(6):503-14. PubMed ID: 15601444 [TBL] [Abstract][Full Text] [Related]
24. Simultaneous quantification of linezolid, tinidazole, norfloxacin, moxifloxacin, levofloxacin, and gatifloxacin in human plasma for therapeutic drug monitoring and pharmacokinetic studies in human volunteers. Helmy SA Ther Drug Monit; 2013 Dec; 35(6):770-7. PubMed ID: 24061442 [TBL] [Abstract][Full Text] [Related]
25. Therapeutic drug monitoring of antimicrobials. Balakrishnan I; Shorten RJ Ann Clin Biochem; 2016 May; 53(Pt 3):333-46. PubMed ID: 26554904 [TBL] [Abstract][Full Text] [Related]
26. Protease inhibitor plasma concentrations in HIV antiretroviral therapy. Justesen US Dan Med Bull; 2008 Nov; 55(4):165-85. PubMed ID: 19232158 [TBL] [Abstract][Full Text] [Related]
27. The effect of carbapenem antibiotics on plasma concentrations of valproic acid. Mancl EE; Gidal BE Ann Pharmacother; 2009 Dec; 43(12):2082-7. PubMed ID: 19934386 [TBL] [Abstract][Full Text] [Related]
28. [FARMAC: a program designed for monitoring the prescription of antimicrobials in hospitals]. Medina-Cuevas F; Navarrete-Navarro S; Avila-Figueroa C; Santos-Preciado JI Gac Med Mex; 2000; 136(2):107-11. PubMed ID: 10815321 [TBL] [Abstract][Full Text] [Related]
29. Antimicrobial drug resistance. Martinez M; Silley P Handb Exp Pharmacol; 2010; (199):227-64. PubMed ID: 20204590 [TBL] [Abstract][Full Text] [Related]
30. Therapeutic monitoring, the concentration-effect relationship and impact on the clinical efficacy of antibiotic agents. Dawson SJ; Reeves DS J Chemother; 1997 May; 9 Suppl 1():84-92. PubMed ID: 9248966 [TBL] [Abstract][Full Text] [Related]
31. [The history of the development and changes of quinolone antibacterial agents]. Takahashi H; Hayakawa I; Akimoto T Yakushigaku Zasshi; 2003; 38(2):161-79. PubMed ID: 15143768 [TBL] [Abstract][Full Text] [Related]
32. A HPLC-MS method for the simultaneous quantification of fourteen antiretroviral agents in peripheral blood mononuclear cell of HIV infected patients optimized using medium corpuscular volume evaluation. D'Avolio A; Simiele M; Siccardi M; Baietto L; Sciandra M; Oddone V; Stefani FR; Agati S; Cusato J; Bonora S; Di Perri G J Pharm Biomed Anal; 2011 Mar; 54(4):779-88. PubMed ID: 21071165 [TBL] [Abstract][Full Text] [Related]
33. Cell disposition of raltegravir and newer antiretrovirals in HIV-infected patients: high inter-individual variability in raltegravir cellular penetration. Fayet Mello A; Buclin T; Franc C; Colombo S; Cruchon S; Guignard N; Biollaz J; Telenti A; Decosterd LA; Cavassini M J Antimicrob Chemother; 2011 Jul; 66(7):1573-81. PubMed ID: 21508009 [TBL] [Abstract][Full Text] [Related]
34. Intracellular and plasma pharmacokinetics of nelfinavir and M8 in HIV-infected patients: relationship with P-glycoprotein expression. Ford J; Cornforth D; Hoggard PG; Cuthbertson Z; Meaden ER; Williams I; Johnson M; Daniels E; Hsyu P; Back DJ; Khoo SH Antivir Ther; 2004 Feb; 9(1):77-84. PubMed ID: 15040539 [TBL] [Abstract][Full Text] [Related]
35. Review of therapeutic drug monitoring of anticancer drugs part 1--cytotoxics. Paci A; Veal G; Bardin C; Levêque D; Widmer N; Beijnen J; Astier A; Chatelut E Eur J Cancer; 2014 Aug; 50(12):2010-9. PubMed ID: 24889915 [TBL] [Abstract][Full Text] [Related]
36. Mycophenolic acid quantification in human peripheral blood mononuclear cells using liquid chromatography-tandem mass spectrometry. Nguyen Thi MT; Capron A; Mourad M; Wallemacq P Clin Biochem; 2013 Dec; 46(18):1909-11. PubMed ID: 24060731 [TBL] [Abstract][Full Text] [Related]
37. Therapeutic drug monitoring in rheumatic diseases: utile or futile? Stamp LK; Barclay M Rheumatology (Oxford); 2014 Jun; 53(6):988-97. PubMed ID: 24196384 [TBL] [Abstract][Full Text] [Related]
38. Intracellular pharmacokinetics of antiretroviral agents. Owen A; Khoo SH J HIV Ther; 2004 Nov; 9(4):97-101. PubMed ID: 15731742 [TBL] [Abstract][Full Text] [Related]
39. The role of therapeutic drug monitoring in the management of patients with human immunodeficiency virus infection. Pretorius E; Klinker H; Rosenkranz B Ther Drug Monit; 2011 Jun; 33(3):265-74. PubMed ID: 21566505 [TBL] [Abstract][Full Text] [Related]